Evgenia E Halkia - Gynecology

Author Information

Evgenia Halkia is affiliated with the Department of Obstetrics and Gynecology at Tzaneio General Hospital in Pireaus, Greece. Her work primarily focuses on gynecological oncology, with a particular emphasis on ovarian cancer and peritoneal carcinomatosis. Her research contributions have significantly impacted the field, particularly in the areas of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Research Contributions

Evgenia Halkia has extensively researched treatment strategies for ovarian cancer and peritoneal carcinomatosis. Her studies on multimodal treatment considerations and advancements in treatment algorithms have highlighted the importance of a multidisciplinary approach in managing these complex conditions. Notable works include addressing hepatic metastases in ovarian cancer and exploring the roles of neoadjuvant, adjuvant, and intraperitoneal chemotherapy. Her research has provided valuable insights into the effectiveness of cytoreductive surgery combined with HIPEC, as well as the potential benefits of staging laparoscopy in predicting cytoreduction outcomes.

Aliases

Evgenia Halkia is also known by several aliases, including E Halkia, E. Halkia, and Evgenia E Halkia.

Publication and Citation Metrics

Citation Count	1006
h-index	12
Paper Count	28

Publications:

Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach

DOI: 10.4254/wjh.v13.i9.1122

Year: 2021

2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations: A Brief Review

DOI: 10.9734/BPI/HMMR/V7/7824D

Year: 2021

2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations

DOI: 10.1155/2018/5284814

Year: 2018

Different Degrees of Small Bowel Involvement in Peritoneal Carcinomatosis may Predict the Completeness of Cytoreduction Score. Is there a Role for Staging Laparoscopy

DOI: 10.15406/ghoa.2017.08.00263

Year: 2017

Neoadjuvant, adjuvant and long-term intravenous/intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, early postoperative intraperitoneal chemotherapy for ovarian cancer

DOI: 10.4081/JOPER.2017.59

Year: 2017

Neoadjuvant chemotherapy in epithelial ovarian cancer

DOI:

Year: 2017

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

DOI: 10.3747/co.23.2831

Year: 2016

Clinical history of patients with peritoneal carcinomatosis exluded from cytoreductive surgery & HIPEC.

DOI:

Year: 2015

The role of cytoreductive surgery and HIPEC in epithelial ovarian cancer.

DOI:

Year: 2015

Is cholecystectomy and removal of the round ligament of the liver a necessary step in cytoreductive surgery and HIPEC, for peritoneal carcinomatosis?

DOI:

Year: 2015

How Can Teenagers Manage Premenstrual Syndrome (PMS)?

How is Tubal Surgery Performed?

Why is PHM Important in Gynecology?

What Role do Mentors Play in Residency?

What are the benefits of seeing a licensed healthcare provider for gynecological care?

What is Lymphoma?

How does a Gynecologist handle emergencies?

How Effective is Permanent Birth Control?

Why are Online Databases Important?

What is Sclerotherapy?

Partnered Content Networks

Relevant Topics